Research Analysts Set Expectations for MMSI FY2027 Earnings

Merit Medical Systems, Inc. (NASDAQ:MMSI) – Zacks Research upped their FY2027 earnings per share (EPS) estimates for shares of Merit Medical Systems in a report released on Thursday, November 20th. Zacks Research analyst Team now anticipates that the medical instruments supplier will post earnings per share of $3.82 for the year, up from their previous forecast of $3.76. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Merit Medical Systems’ current full-year earnings is $3.37 per share.

MMSI has been the topic of several other reports. Piper Sandler reiterated an “overweight” rating and set a $109.00 price objective (up from $105.00) on shares of Merit Medical Systems in a research report on Friday, October 31st. Wells Fargo & Company reduced their target price on shares of Merit Medical Systems from $103.00 to $95.00 and set an “overweight” rating on the stock in a report on Friday, November 14th. Robert W. Baird set a $103.00 price target on shares of Merit Medical Systems in a research note on Friday, October 31st. Needham & Company LLC restated a “buy” rating and set a $108.00 price target on shares of Merit Medical Systems in a research report on Friday, October 31st. Finally, Barrington Research reaffirmed an “outperform” rating and set a $106.00 price objective on shares of Merit Medical Systems in a research note on Friday, November 14th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $104.50.

Merit Medical Systems Stock Up 2.7%

Shares of NASDAQ:MMSI opened at $87.20 on Monday. The company has a market cap of $5.17 billion, a price-to-earnings ratio of 44.26, a PEG ratio of 2.62 and a beta of 0.64. The company has a debt-to-equity ratio of 0.49, a current ratio of 4.09 and a quick ratio of 2.66. The firm has a fifty day moving average price of $83.81 and a two-hundred day moving average price of $88.49. Merit Medical Systems has a one year low of $78.12 and a one year high of $111.45.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Thursday, October 30th. The medical instruments supplier reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.10. Merit Medical Systems had a return on equity of 15.07% and a net margin of 8.31%.The firm had revenue of $384.16 million for the quarter, compared to analysts’ expectations of $371.69 million. During the same period in the prior year, the business posted $0.86 earnings per share. The company’s revenue was up 13.0% on a year-over-year basis. Merit Medical Systems has set its FY 2025 guidance at 3.660-3.790 EPS.

Insiders Place Their Bets

In other Merit Medical Systems news, Chairman Fred P. Lampropoulos sold 20,000 shares of the firm’s stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $85.13, for a total value of $1,702,600.00. Following the sale, the chairman owned 1,054,955 shares of the company’s stock, valued at $89,808,319.15. This trade represents a 1.86% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 3.20% of the stock is owned by insiders.

Institutional Trading of Merit Medical Systems

A number of institutional investors have recently modified their holdings of MMSI. Maseco LLP purchased a new position in Merit Medical Systems during the 2nd quarter valued at about $28,000. IFP Advisors Inc lifted its holdings in Merit Medical Systems by 1,435.0% in the 1st quarter. IFP Advisors Inc now owns 307 shares of the medical instruments supplier’s stock worth $32,000 after buying an additional 287 shares during the period. MassMutual Private Wealth & Trust FSB grew its position in shares of Merit Medical Systems by 55.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 375 shares of the medical instruments supplier’s stock worth $35,000 after buying an additional 134 shares during the last quarter. Salomon & Ludwin LLC purchased a new position in shares of Merit Medical Systems during the third quarter valued at approximately $37,000. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in shares of Merit Medical Systems by 119.8% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 367 shares of the medical instruments supplier’s stock valued at $39,000 after acquiring an additional 200 shares in the last quarter. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.